These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 22699819)
21. Inflammatory markers and hepatocyte growth factor in sustained hemodialysis hypotension. Lee CT; Hsu CY; Lam KK; Lin CR; Chen JB Artif Organs; 2005 Dec; 29(12):980-3. PubMed ID: 16305655 [TBL] [Abstract][Full Text] [Related]
22. Effect of diet-induced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome. Heinonen MV; Laaksonen DE; Karhu T; Karhunen L; Laitinen T; Kainulainen S; Rissanen A; Niskanen L; Herzig KH Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):626-33. PubMed ID: 19278844 [TBL] [Abstract][Full Text] [Related]
23. Osmolality and blood pressure stability during hemodialysis. Singh AT; Mc Causland FR Semin Dial; 2017 Nov; 30(6):509-517. PubMed ID: 28691402 [TBL] [Abstract][Full Text] [Related]
24. Apelin: a peptide involved in cardiovascular risk in hemodialysis patients? Leal VO; Lobo JC; Stockler-Pinto MB; Farage NE; Calixto A; Geloneze B; Mafra D Ren Fail; 2012; 34(5):577-81. PubMed ID: 22417287 [TBL] [Abstract][Full Text] [Related]
25. Apelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure. Liakos CI; Sanidas EA; Perrea DN; Grassos CA; Chantziara V; Viniou NA; Barbetseas JD; Papadopoulos DP Am J Hypertens; 2016 May; 29(5):549-52. PubMed ID: 26276791 [TBL] [Abstract][Full Text] [Related]
26. Role of AVP in the regulation of vascular tonus and blood pressure in patients with chronic renal failure. Yamada K; Nakayama M; Miura Y; Nakano H; Mimura N; Yoshida S Regul Pept; 1993 Apr; 45(1-2):91-5. PubMed ID: 8511371 [TBL] [Abstract][Full Text] [Related]
27. Apelin, a novel adipocytokine, in relation to endothelial function and inflammation in kidney allograft recipients. Malyszko J; Malyszko JS; Pawlak K; Wolczynski S; Mysliwiec M Transplant Proc; 2008 Dec; 40(10):3466-9. PubMed ID: 19100414 [TBL] [Abstract][Full Text] [Related]
28. [Hemodynamic effects of an inhibitor of the vascular effects of vasopressin in patients with congestive heart failure]. Nicod P; Goy J; Waeber B; Bussien JP; Turini GA; Nussberger J; Hofbauer KG; Brunner HR Schweiz Med Wochenschr; 1985 Dec; 115(50):1823-5. PubMed ID: 3841412 [TBL] [Abstract][Full Text] [Related]
29. Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease--KOZANI STUDY. Kadoglou NP; Lampropoulos S; Kapelouzou A; Gkontopoulos A; Theofilogiannakos EK; Fotiadis G; Kottas G Transl Res; 2010 May; 155(5):238-46. PubMed ID: 20403579 [TBL] [Abstract][Full Text] [Related]
30. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Elsharkawy MM; Youssef AM; Zayoon MY Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745 [TBL] [Abstract][Full Text] [Related]
31. Apelin and cardiac function in hemodialyzed patients: possible relations? Małyszko J; Małyszko JS; Koźminski P; Myśliwiec M Am J Nephrol; 2006; 26(2):121-6. PubMed ID: 16549903 [TBL] [Abstract][Full Text] [Related]
32. Hypotension in end-stage renal disease: effect of postural change, exercise and angiotensin II infusion on blood pressure and plasma concentrations of angiotensin II, aldosterone and arginine vasopressin in hypotensive patients with chronic renal failure treated by dialysis. Sørensen SS; Danielsen H; Jespersen B; Pedersen EB Clin Nephrol; 1986 Dec; 26(6):288-96. PubMed ID: 3802595 [TBL] [Abstract][Full Text] [Related]
33. Changes of plasma arginine-vasopressin level in patients with hyperthyroidism during treatment. Marcisz C; Jonderko G; Kucharz EJ Med Sci Monit; 2001; 7(3):409-14. PubMed ID: 11386017 [TBL] [Abstract][Full Text] [Related]
34. Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus. Kadoglou NP; Tsanikidis H; Kapelouzou A; Vrabas I; Vitta I; Karayannacos PE; Liapis CD; Sailer N Metabolism; 2010 Mar; 59(3):373-9. PubMed ID: 19815243 [TBL] [Abstract][Full Text] [Related]
35. Failure of AVP and other pressor hormones to increase in severe recurrent dialysis hypotension. Zoccali C; Mallamaci F Nephrol Dial Transplant; 1996 Feb; 11(2):402-3. PubMed ID: 8700377 [No Abstract] [Full Text] [Related]
36. Adrenergic regulation of blood pressure in chronic renal failure. Lilley JJ; Golden J; Stone RA J Clin Invest; 1976 May; 57(5):1190-200. PubMed ID: 1262465 [TBL] [Abstract][Full Text] [Related]
38. Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuli. Azizi M; Iturrioz X; Blanchard A; Peyrard S; De Mota N; Chartrel N; Vaudry H; Corvol P; Llorens-Cortes C J Am Soc Nephrol; 2008 May; 19(5):1015-24. PubMed ID: 18272843 [TBL] [Abstract][Full Text] [Related]
39. Association of human hepatocyte growth factor with hemodialysis hypotension. Nishimura M; Ushiyama M; Maruyama Y; Mabuchi H; Takahashi H; Yoshimura M Hypertens Res; 2000 Nov; 23(6):581-6. PubMed ID: 11131269 [TBL] [Abstract][Full Text] [Related]
40. The reflex control of vasopressin in haemodialysis patients. Zoccali C; Mallamaci F; Ciccarelli M; Parlongo S; Salnitro F; Curatola A Nephrol Dial Transplant; 1991; 6(9):631-6. PubMed ID: 1745386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]